New Drug Approach Prevents Dangerous Blood Sugar Crashes in Diabetic Rats
Somatostatin receptor antagonist enhances protective glucagon response during hypoglycemia without worsening diabetes control.
6570 articles
Somatostatin receptor antagonist enhances protective glucagon response during hypoglycemia without worsening diabetes control.
Researchers discover that corticosteroid-binding globulin therapy dramatically reduces septic shock mortality and organ damage.
Research reveals ฮฑ1-acid glycoprotein could protect against metabolic liver disease by targeting both liver and fat tissue dysfunction.
Scientists discover membrane proteins that control progesterone signaling, potentially revolutionizing reproductive health and longevity.
New research reveals growth hormone regulates lymphatic vessels, opening potential therapeutic targets for immune and metabolic health.
New research reveals how restricted growth in the womb alters pancreatic immune cells, potentially explaining lifelong diabetes risk.
Researchers found that blocking selenoprotein P in the brain reduces anxiety-like behavior caused by high-fat, high-sugar diets.
New research challenges assumptions about PCOS risks during pregnancy, finding similar outcomes except for one key difference.
New research reveals that seemingly harmless adrenal gland tumors can become cancerous after remaining stable for over a decade.
Study finds exenatide enhances endogenous GLP-1 secretion in type 2 diabetes patients, potentially improving metabolic health.
New study shows CGM metrics better predict diabetic nerve damage in the eye than traditional blood sugar tests alone.
Study of extreme insulin resistance reveals IGF-1 therapy provides only temporary benefits before patients develop diabetes.